These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35024332)

  • 21. Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    Zheng D; Li J; Huang BH; Liu JR; Zou WY; Su C
    Chin Med J (Engl); 2012 Dec; 125(24):4454-9. PubMed ID: 23253719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory multiple myeloma harboring t(11,14)(q13;q32): two case reports and a review of the literature.
    Abuelgasim KA; Alherz N; Alhejazi A; Damlaj M
    J Med Case Rep; 2020 Apr; 14(1):54. PubMed ID: 32321588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
    Blood; 1995 Jun; 85(11):3077-85. PubMed ID: 7756641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
    Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
    Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case of Advanced Primary Thyroid Double-Hit B Cell Lymphoma in Which Complete Remission has been Maintained After High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Performed During the Second Remission, with a Review of the Literature.
    Sekiguchi Y; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):166-73. PubMed ID: 25332569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation.
    Santos Gda C; Saieg MA; Ko HM; Geddie WR; Boerner SL; Craddock KJ; Crump M; Bailey D
    Cancer Cytopathol; 2015 Jul; 123(7):413-20. PubMed ID: 25807917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma.
    Glitza IC; Lu G; Shah R; Bashir Q; Shah N; Champlin RE; Shah J; Orlowski RZ; Qazilbash MH
    Leuk Lymphoma; 2015 Mar; 56(3):602-7. PubMed ID: 24844357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
    Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
    Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Bischin AM; Dorer R; Aboulafia DM
    Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
    Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint MT; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A
    J Clin Oncol; 1999 Jan; 17(1):208-15. PubMed ID: 10458235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase.
    Monaco S; Tsao L; Murty VV; Nandula SV; Donovan V; Oesterheld J; Bhagat G; Alobeid B
    Am J Hematol; 2007 Jan; 82(1):59-64. PubMed ID: 16955462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis.
    Wach M; Cioch M; Hus M; Jawniak D; Legiec W; Malek M; Manko J; Walter-Croneck A; Wasik-Szczepanek E; Dmoszynska A
    Folia Histochem Cytobiol; 2011; 49(2):248-54. PubMed ID: 21744324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of Chromosome Abnormality on Therapeutic Efficacy and Prognosis of Newly Diagnosed Multiple Myeloma Treated with Bortezomib].
    Sun C; Wang J; Guo HF; Zhou X; Shen YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):142-146. PubMed ID: 28245391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [B-cell acute lymphoblastic leukemia developed 5 years after autologous stem cell transplantation for multiple myeloma].
    Tsukada Y; Hattori Y; Nakajima H; Yokoyama K; Murata M; Shimizu N; Kondo N; Okamoto S
    Rinsho Ketsueki; 2012 Feb; 53(2):219-23. PubMed ID: 22450582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
    Gabrea A; Martelli ML; Qi Y; Roschke A; Barlogie B; Shaughnessy JD; Sawyer JR; Kuehl WM
    Genes Chromosomes Cancer; 2008 Jul; 47(7):573-90. PubMed ID: 18381641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
    Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
    Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic appearance of AIDS-related gastrointestinal lymphoma with c-MYC rearrangements: case report and literature review.
    Tanaka S; Nagata N; Mine S; Igari T; Kobayashi T; Sugihara J; Honda H; Teruya K; Kikuchi Y; Oka S; Uemura N
    World J Gastroenterol; 2013 Aug; 19(29):4827-31. PubMed ID: 23922484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.